PISCATAWAY, N.J., April 8, 2025 /PRNewswire/ — GenScript Biotech Corporation (GenScript), a global leader in life sciences research, manufacturing technologies, and production services, has released its 2024 Environmental, Social, and Governance (ESG) report. The report […]
Tag: GenScript Biotech Corporation
SBTi Verifies GenScript Biotech Corp’s Carbon Emission Reduction Goals, Marking a Major Sustainability Milestone!
PISCATAWAY, N.J., Feb. 18, 2025 /PRNewswire/ — GenScript Biotech Corp, a global leader in life sciences R&D and manufacturing services, today announced that it is committing to aggressive carbon emission reduction targets. These targets have […]
GenScript Biotech Sets Up New Operations and Logistics Hub in Sydney, Australia
PISCATAWAY, N.J., Nov. 10, 2024 /PRNewswire/ — GenScript Biotech Corporation (“GenScript”), a global leader in life sciences services and products, has announced the establishment of new operations site and logistics center in Sydney, Australia. This […]
Join the 2024 GenScript Biotech Global Forum for Cutting-Edge Insights
PISCATAWAY, N.J., Oct. 24, 2024 /PRNewswire/ — Cell therapy, gene therapy, and mRNA vaccines are revolutionizing healthcare, offering innovative treatments for a wide range of diseases. However, as these therapies progress, they encounter challenges like safety […]
Dialogue with CGT Leaders! You Are Invited to Join the “2024 GenScript Biotech Global Forum•London” to Discuss the Future Together
PISCATAWAY, N.J., Sept. 14, 2024 /PRNewswire/ — The year 2024 marks a milestone year for continuous advancements in Cell and Gene Therapy (CGT). The global launch of Amtagvi, a Tumor-Infiltrating Lymphocyte (TIL) therapy, has ushered […]